• Subscribe
  • Magazine
  • Past Issues
  • Surveys
  • Industry Statistics
  • About Us
  • Members Only
  • Best Places to Work
    • Recent Quotes
    My Watchlist
    Indicators
    PennEnergy Stock Watch
    Markets
    Stocks
    ETFs
    Tools
    Overview
    News
    Currencies
    International
    Treasuries

    Oragenics Inc (NY: OGEN )

    1.710 UNCHANGED
    Streaming Delayed Price Updated: 8:00 PM EDT, Jun 12, 2024 Add to My Watchlist
    Quote
    Overview Detailed Quote Charting Historical Prices
    News
    All News News Headlines Press Releases
    Research
    Quarterly Reports Insider Filings Other Filings

    Price and Volume

    Detailed Quote
    Volume 0
    Open 1.710
    Bid (Size) 1.600 (1)
    Ask (Size) 2.730 (2)
    Prev. Close 1.710
    Today's Range 1.710 - 1.710
    52wk Range 1.000 - 7.740
    Shares Outstanding 4,480,693
    Dividend Yield N/A
    Chart for (: )
    Intraday 1 Week 1 Month 3 Month 1 Year 3 Year 5 Year

    Top News

    More News
    12 Health Care Stocks Moving In Wednesday's After-Market Session
    Via Benzinga
    Nasdaq Falls Over 100 Points; TJX Posts Upbeat Q1 Results
    Via Benzinga

    Performance

    YTD
    -74.78%
    -74.78%
    1 Month
    +14.00%
    +14.00%
    3 Month
    +18.75%
    +18.75%
    6 Month
    -65.59%
    -65.59%
    1 Year
    -43.93%
    -43.93%

    More News

    Read More
    Why XP Shares Are Trading Lower By Around 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    OGEN Stock Earnings: Oragenics Reported Results for Q1 2024
    Via InvestorPlace
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Gold Down Over 1%; Williams-Sonoma Posts Strong Earnings
    Via Benzinga
    12 Health Care Stocks Moving In Monday's Intraday Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's After-Market Session
    Via Benzinga
    12 Health Care Stocks Moving In Tuesday's Intraday Session
    Via Benzinga
    Oragenics, Inc. Announces Notification of Noncompliance with Additional NYSE American Continued Listing Standards
    From Oragenics, Inc.
    Via Business Wire
    Oragenics, Inc. Files 10K and Provides Company Update
    From Oragenics, Inc.
    Via Business Wire
    Oragenics Appoints James Kelly MD, Chief Medical Officer, to Lead Phase II Clinical Trials for Treating Concussion
    From Oragenics, Inc.
    Via Business Wire
    Oragenics, Inc. Prepares Drug for Phase II Clinical Trials to Treat Concussion
    From Oragenics, Inc.
    Via Business Wire
    Oragenics Announces Closing of Public Offering
    From Oragenics, Inc.
    Via Business Wire
    S&P 500 Edges Lower; ADT Posts Upbeat Earnings
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    12 Health Care Stocks Moving In Wednesday's Intraday Session
    Via Benzinga
    Why Bumble Shares Are Trading Lower By 12%? Here Are Other Stocks Moving In Wednesday's Mid-Day Session
    Via Benzinga
    Nasdaq Down 50 Points; US Crude Stocks Rise By 4.2M Barrels
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Dow Dips 200 Points; TJX Posts Upbeat Sales
    Via Benzinga
    Topics Stocks
    Exposures US Equities
    Why Is Applied Therapeutics (APLT) Stock Up 59% Today?
    Via InvestorPlace
    Why Is Integral Ad Science (IAS) Stock Down 29% Today?
    Via InvestorPlace
    Why Is Oragenics (OGEN) Stock Down 45% Today?
    Via InvestorPlace
    Why Beyond Meat Shares Are Trading Higher By Around 56%; Here Are 20 Stocks Moving Premarket
    Via Benzinga
    12 Health Care Stocks Moving In Wednesday's Pre-Market Session
    Via Benzinga
    Today’s Biggest Pre-Market Stock Movers: 10 Top Gainers and Losers on Wednesday
    Via InvestorPlace
    Data & News supplied by www.cloudquote.io
    Stock quotes supplied by Barchart
    Quotes delayed at least 20 minutes.
    By accessing this page, you agree to the following
    Privacy Policy and Terms and Conditions.